GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Magellan Health Inc (NAS:MGLN) » Definitions » Beneish M-Score

Magellan Health (Magellan Health) Beneish M-Score : 0.00 (As of Apr. 25, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Magellan Health Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Magellan Health's Beneish M-Score or its related term are showing as below:

During the past 13 years, the highest Beneish M-Score of Magellan Health was 1.09. The lowest was -10.21. And the median was -2.36.


Magellan Health Beneish M-Score Historical Data

The historical data trend for Magellan Health's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Magellan Health Beneish M-Score Chart

Magellan Health Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.29 -2.33 - - -

Magellan Health Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Magellan Health's Beneish M-Score

For the Healthcare Plans subindustry, Magellan Health's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Magellan Health's Beneish M-Score Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Magellan Health's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Magellan Health's Beneish M-Score falls into.



Magellan Health Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Magellan Health for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0896+0.528 * 1.36+0.404 * 0.7626+0.892 * 1.0026+0.115 * 1.0749
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * -0.010223-0.327 * 0.793
=-2.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec20) TTM:Last Year (Dec19) TTM:
Total Receivables was $744 Mil.
Revenue was $4,578 Mil.
Gross Profit was $119 Mil.
Total Current Assets was $2,156 Mil.
Total Assets was $3,360 Mil.
Property, Plant and Equipment(Net PPE) was $137 Mil.
Depreciation, Depletion and Amortization(DDA) was $119 Mil.
Selling, General, & Admin. Expense(SGA) was $0 Mil.
Total Current Liabilities was $738 Mil.
Long-Term Debt & Capital Lease Obligation was $632 Mil.
Net Income was $382 Mil.
Gross Profit was $-34 Mil.
Cash Flow from Operations was $451 Mil.
Total Receivables was $681 Mil.
Revenue was $4,566 Mil.
Gross Profit was $161 Mil.
Total Current Assets was $1,673 Mil.
Total Assets was $3,092 Mil.
Property, Plant and Equipment(Net PPE) was $132 Mil.
Depreciation, Depletion and Amortization(DDA) was $132 Mil.
Selling, General, & Admin. Expense(SGA) was $0 Mil.
Total Current Liabilities was $910 Mil.
Long-Term Debt & Capital Lease Obligation was $679 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(743.502 / 4577.531) / (680.569 / 4565.613)
=0.162424 / 0.149064
=1.0896

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(161.137 / 4565.613) / (118.791 / 4577.531)
=0.035294 / 0.025951
=1.36

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2156.397 + 136.739) / 3359.855) / (1 - (1673.043 + 131.712) / 3092.173)
=0.31749 / 0.416347
=0.7626

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=4577.531 / 4565.613
=1.0026

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(131.509 / (131.509 + 131.712)) / (118.745 / (118.745 + 136.739))
=0.499614 / 0.464784
=1.0749

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 4577.531) / (0 / 4565.613)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((631.855 + 737.579) / 3359.855) / ((679.125 + 910.147) / 3092.173)
=0.407587 / 0.513966
=0.793

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(382.335 - -34.078 - 450.761) / 3359.855
=-0.010223

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Magellan Health has a M-score of -2.27 suggests that the company is unlikely to be a manipulator.


Magellan Health Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Magellan Health's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Magellan Health (Magellan Health) Business Description

Traded in Other Exchanges
N/A
Address
4801 E. Washington Street, Suite 4400, Phoenix, AZ, USA, 85034
Magellan Health provides healthcare management services to health plans and other managed care organizations, employers, labor unions, United States government agencies, and third-party administrators. The firm operates in three segments: Healthcare, Pharmacy Management, and Corporate. The Healthcare business manages behavioral healthcare services and employee assistance program services, as well as specialty areas like diagnostic imaging. The Pharmacy Management segment includes pharmacy benefit management (PBM) services, pharmacy benefit administration for Medicaid and other government-sponsored programs, pharmaceutical dispensing operations, and clinical and formulary management programs. The Healthcare business generates the majority of revenue.
Executives
Mostafa Kamal officer: CEO, Magellan Rx Management 15950 NORTH 76TH STREET, #200 SCOTTSDALE AZ 85260
Jeffrey N West officer: SVP & Controller 6950 COLUMBIA GATEWAY DR STE 400 COLUMBIA MD 21046
David Bourdon officer: Chief Financial Officer 6303 COWBOYS WAY, SUITE 350, FRISCO TX 75034
Peter A Feld director 201 E LAS OLAS BOULEVARD, SUITE 1000, FORT LAUDERDALE FL 33301
Swati Bargotra Abbott director 4800 NORTH SCOTTSDALE ROAD, SUITE 4400, SCOTTSDALE AZ 85251
Steven J Shulman director 1564 NE EXPRESSWAY, ATTN: BJ PURCELL, ATLANTA GA 30329
Guy P Sansone director C/O MEDNAX, 1301 CONCORD TERRACE, SUNRISE FL 33323
Gregory Scott Mackenzie director NDC PLAZA ATLANTA GA 30329
Leslie V Norwalk director C/O 3661 VALLEY CENTRE DRIVE SUITE 200, SAN DIEGO CA 92130
Christopher J Chen director 4801 EAST WASHINGTON STREET PHOENIX AZ 85034
Mural R Josephson director
James E Murray officer: President and COO 500 WEST MAIN STREET, LOUISVILLE KY 40202
Clapper Caskie Lewis officer: Chief Human Resources Officer 55 NOD ROAD AVON CT 06001
Kenneth J Fasola director, officer: Chief Executive Officer 500 WEST MAIN STREET, LOUISVILLE KY 40202
Jonathan N Rubin officer: Chief Financial Officer 55 NOD ROAD AVON CT 06001

Magellan Health (Magellan Health) Headlines

From GuruFocus

Magellan Health and Gallup Team Up to Measure and Increase Wellbeing

By Business Wire Business Wire 11-01-2021

Magellan Rx Pharmacy Earns NABP Digital Pharmacy Accreditation

By Business Wire Business Wire 10-07-2021